Comparison

B&D vs InjectorMate

Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.

Head to head
About

B&D

This app streamlines the documentation of Botox and Dermal Filler treatments for cosmetic clinics. It allows for detailed charting, patient history tracking, digital consent forms, and automated PDF report generation. The tool simplifies unit tracking and offers white-labeling options for clinics.

Highlights
  • Botox/Dermal Filler charting
  • Digital consent forms with signatures
  • Pre-operative photo integration
  • Automated PDF report generation
  • Drag and drop interface for unit tracking
  • Patient treatment history
  • White-labeling with clinic branding
Features
Read full description

Botox and Dermal Charting app is the ultimate tool to administer Botox and/or Dermal Filler treatments in a cosmetic clinic. The app simplifies the charting and documentation for Botox and Dermal Filler treatments. The application gathers information such as the patient's health history, custom consent forms with digital signatures, pre-operative photographs using the integrated iPad camera, and then actually charting the increments used (of botox and dermal fillers).  • The clinic can document Botox increments with a "drag and drop" interface onto a stock face structure or patient photographs.  • The units are automatically added so the clinician can quickly determine the number of Botox (or Dysport) units delivered to that patient.  • Track units and orientation on a simple drag and drop interface. • Simple color-coded dose tracking. • Patient Treatment History. • Manage dose information within the app. • Automatically generate a detailed PDF report with procedure details. • Custom Consent Forms. • Print, email, or export the PDF report. • Save to cloud storage (Dropbox)  • White Label with the clinic's branding and logo. This app is designed for the iPad only. Terms of Use: https://ocdlab.co/nl-en/terms-of-use

About

InjectorMate

This augmented reality application allows users to practice facial injection techniques on virtual patients. It offers various treatment patterns for common aesthetic concerns and serves as a training tool for both new and experienced professionals.

Highlights
  • Augmented reality injection practice
  • Virtual patient simulation
  • Multiple treatment patterns
  • Training for aesthetic therapy
  • Skill retraining for professionals
Features
Read full description

Practice different angles and approaches and on any patient you choose. Multiple different patterns of treatment provided: crow’s feet, forehead creases, frown lines. InjectorMate is the perfect training tool for entrants into the exciting new field of aesthetic therapy and is highly effective for retraining and practicing skills even for seasoned professionals. Designed and powered by MachineMedicine Technologies by clinicians and for clinician use. Disclaimer: this is a purely educational app providing an augmented reality injection experience. It is not for providing diagnosis or treatment and cannot be used as such. Please see your physician for any medical diagnoses or plans.

Screenshots

InjectorMate3 screens

Verdict

The call

The clearest difference is review sentiment: InjectorMate at 100% against B&D's 33%. InjectorMate also leads on in-app purchases (none vs 2) and update cadence (every 5 days vs monthly). B&D's advantage is rating (2.5 vs 1.0) and ratings volume (4 vs 1). On price and ads there is nothing between them.

Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS

CostPrice · In-app purchases · Ads · Monetization

Both are free to download. B&D sells 2 in-app purchases, starting at $9.99 per month. InjectorMate asks for nothing beyond the download.

ReceptionRating · Positive reviews · Number of ratings

B&D holds the better App Store score, 2.5 against 1.0. Both are backed by a comparable volume of ratings — 4 and 1 respectively. Written reviews complicate that: 33% of B&D's written reviews are positive against 100% of InjectorMate's, so the app with the better star average is not the one people write more warmly about.

UpkeepUpdate frequency

B&D ships an update monthly, InjectorMate every 5 days. The most recent releases landed on November 3, 2026 and November 4, 2026 respectively.

Scorecard8 real differences · 2 level
B&D versus InjectorMate: the parameters behind the verdict, then further details
ParameterB&DInjectorMate
PriceFreeFree
Rating2.5 (4 ratings) — better1.0 (1 ratings)
Positive reviews33.3% of reviews100.0% of reviews — better
Number of ratings4 — better1
Update frequencyMonthlyEvery 5 days — better
AdsNoNo
In-app purchasesYesNo — better
MonetizationFree with in-app purchasesFree — better
DevicesiPadiPhone, iPad, iPod — better
Requires iOS12.0 — better15
Further details — not scored
Size43 MB19 MB
Age rating4+4+
DeveloperOCDLab B.V.MACHINE MEDICINE TECHNOLOGIES LIMITED

Customer experience

B&D

All ratings4 ratings
Positive25.0%
Neutral25.0%
Negative50.0%
Written reviews3 reviews
Positive33.3%
Neutral0.0%
Negative66.7%

InjectorMate

All ratings1 ratings
Positive0.0%
Neutral0.0%
Negative100.0%
Written reviews5 reviews
Positive100.0%
Neutral0.0%
Negative0.0%

In-app purchases

2 purchases

B&D

Subscriptions2
  • BnD monthly subscription7 Days trial$9.991 Month
  • BnD annual subscription7 Days trial$89.991 Year
None

InjectorMate

No in-app purchases

Questions

Is B&D free?
B&D is free to download, with in-app purchases available.
Is InjectorMate free?
InjectorMate is free to download, with no in-app purchases.
Which has better reviews, B&D or InjectorMate?
B&D is rated higher. B&D averages 2.5 out of 5 from 4 ratings, while InjectorMate averages 1.0 from 1 ratings.
Do B&D or InjectorMate have ads?
Neither B&D nor InjectorMate shows ads.
Which is updated more often, B&D or InjectorMate?
B&D ships an update monthly, and InjectorMate every 5 days. Most recently, B&D was updated on November 3, 2026 and InjectorMate on November 4, 2026.

Other comparisons